Alzchem Stock - analyst consensus and background on the specialty chemicals group

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 07:40 CET. Details in the imprint.

Alzchem (DE000A2YN1X2) remains without a new ad-hoc release or major wire report this weekend. Instead, the focus for investors falls on the existing analyst consensus, recent results and the specialty chemicals group’s positioning in its niche markets.

What recent reports show

Alzchem Group AG describes itself as a vertically integrated specialty chemicals supplier with a focus on nitrogen-based chemistry, running production sites in Germany and Sweden plus sales offices worldwide, according to its investor-relations material. IR overview

The company emphasizes stable end-markets in life sciences, nutrition, agriculture and fine chemicals, while also supplying basic chemistry products used in various industrial applications. Company profile

Analyst coverage and consensus

Coverage of Alzchem stock remains relatively limited compared with larger German chemical names, but financial portals summarizing analyst views point to a small number of houses with a broadly constructive stance on the medium-term earnings profile. Consensus data

Consensus estimates compiled by such services indicate expectations for modest revenue growth over the coming years, supported by higher value-added specialties and efficiency measures, though the precise figures vary by source and are subject to regular revision.

What the company sells

Alzchem generates its revenue from a portfolio that includes guanidine derivatives, the dietary supplement creatine, plant growth regulator products and various intermediates for pharmaceuticals, agrochemicals and other industrial applications.

Where the stock trades today

The shares of Alzchem (DE000A2YN1X2) are listed in Germany, with the most relevant trading venue for many investors being Xetra; the latest available price information can be obtained from German exchange portals and real-time quote services.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.